ChAdOx1 adenovirus viral vector

Black Death Vaccine: First Phase of Human Trials Begins, Will This End the Bubonic Plague?

Medicine & Technology Aug 03, 2021

Researchers from the University of Oxford have launched their first human trial for a new vaccine for Black Death, taking inspiration from the success of their COVID-19 vaccine.

ChAdOx1 adenovirus viral vector

Black Death Vaccine: First Phase of Human Trials Begins, Will This End the Bubonic Plague?

Most Popular

Sports Supplements For Brain Health? Creatinine May Improve Cognitive Ability Among the Sleep-Deprived, Study Reveals

Earth's Magnetic Field Nearly Collapsed 600 Million Years Ago, Sparking Evolution of More Complex Life

'Ugliest Man' With Physical Deformity Finds Love Three Times; What Is Fibrodysplasia Ossificans Progressiva (FOP)?

Extremely Powerful Solar Flare Unleashed by the Sun Triggered Widespread Radio Blackouts Across the Pacific Region

Functional Human Brain Cells Made From Salt and Water Mark Significant Step in Iontronic Neuromorphic Computing

Recommended Stories

Is Mars Like Earth? NASA Rover Finds Substantial Amounts of Manganese on the Red Planet's Gale Crater

‘Cosmic Glitch’ in Einstein’s Theory of General Relativity Could Be Explained in This New Scientific Tweak [Study]

Unique Exoplanet Found Lurking in Habitable Zone of 2 Stars

Eta Aquarids 2024: Halley's Comet Meteor Shower To Peak This Weekend; Here's How To Watch the Cosmic Light Show